Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Cancer Chemotherapy and Pharmacology|January 1, 1994
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.
Biochemical Pharmacology|July 15, 1982
Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Cancer Treatment Reports|March 1, 1983
Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Investigational New Drugs|August 31, 2002
Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642)Desirée Hao, Jinee D Rizzo, Stephanie Stringer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1995
Assessment of skeletal muscle viability by PETG T Smith, T S Wilson, K Hunter, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Positron Emission Tomography (PET) with 1-Aminocyclobutane-1-[(11)C]carboxylic Acid (1-[(11)C]-ACBC) for Detecting Recurrent Brain TumorsK F. Hübner, J A. Thie, G T. Smith, et al.
Anti-Cancer Drugs|August 1, 1993
XB596, a promising bis-naphthalimide anti-cancer agentS F Chen, D L Behrens, C H Behrens, et al.
Cancer Research|January 1, 1994
Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivityR J McRipley, P E Burns-Horwitz, P M Czerniak, et al.
Pageof 20